Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

MELBOURNE, Australia--(BUSINESS WIRE)---- $IBX #FDA--Imagion's IND Application for HER2 MagSense® Imaging Agent Phase 2 Clinical Trial Has Cleared FDA Review. Company to proceed with clinical trial.